Amanda Hoysock’s Post

Dear #Connections , I'm happy to announce that I recently obtained a certificate from Aditya College of Pharmacy for attending the webinar on "Nanoparticles in Drug Delivery Systems." The webinar was very absorbing equipped with cutting-edge knowledge in leveraging nanoparticles for advanced drug delivery within the pharmaceutical industry. Passionate about harnessing innovative technologies to enhance therapeutic efficacy, minimize side effects, and improve patient outcomes. Eager to apply newfound expertise to contribute to the development of next-generation pharmaceutical products. Proven ability to adapt to evolving industry trends and collaborate effectively across multidisciplinary teams.The key topics of the webinar include : *Nanoparticle Synthesis and Characterization *Drug Delivery System Design *Pharmacokinetics and Pharmacodynamics *Regulatory Compliance *Pharmaceutical Product Development *Cross-functional Collaboration *Research and Analysis #nanoparticles #webinar #pharmaceuticals #fresher #learningeveryday #lookingforjob #qualitycontrol #qualityassurance

𝐅𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐎𝐮𝐭𝐬𝐨𝐮𝐫𝐜𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟑𝟒 ▶𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/dHMe3iuY The Formulation Development Outsourcing Market, valued at USD 33.9 billion in 2023, is projected to grow at a CAGR of 7% and reach USD 71.5 billion by 2034. This market involves hiring external entities or contract research and development firms to manage the development of pharmaceutical or chemical formulations, enabling businesses to leverage external expertise for developing stable and manufacturable products. By outsourcing, companies can streamline processes, reduce costs, and speed up time-to-market. The market growth is driven by the increasing complexity of drug formulations, high demand for innovative pharmaceuticals, and the adoption of cost-effective strategies by pharmaceutical and biotech firms. The abundance of Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) offering specialized services, along with stringent regulatory requirements and rapid advancements in pharmaceutical technology, are further fueling this market. As a result, the industry is expected to experience steady growth due to its continuous focus on research and development activities.   𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: ▶𝐁𝐲 𝐒𝐞𝐫𝐯𝐢𝐜𝐞: Pre-formulations, Formulation Development. ▶𝐁𝐲 𝐅𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧: Oral, Injectable, Topical, Inhaled, Others. ▶𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧: Oncology, Infectious Diseases, Neurology, Hematology, Respiratory, Cardiovascular, Dermatology. ▶𝐁𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫: Pharmaceutical Industries, Research and Academic Institutes, Others. ▶𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧: North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA).   𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐜𝐨𝐯𝐞𝐫𝐞𝐝: Catalent Pharma Solutions, Lonza, Recipharm, Evonik, Patheon, Cambrex, Jubilant Life Sciences (USA) Inc., Aptuit, Curia, Charles River Laboratories, WuXi AppTec, PPD, Pii (Pharmaceutics International, Inc.)   #FormulationDevelopment #PharmaOutsourcing #DrugDevelopment #PharmaceuticalResearch #OutsourcedServices #PharmaInnovation #Biopharma #CDMO #ClinicalResearch #PharmaTrends #DrugFormulation #Pharmaceuticals #PharmaTech #PharmaGrowth #PharmaSolutions #PharmaManufacturing #DrugDiscovery #RandDOutsourcing #HealthcareInnovation #PharmaContractors

𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜𝐬 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬!    I previously wrote about the economics of medical device companies. Specifically, I looked at the economics of some of the medical device companies. For this post, I thought I compare their economics with that of pharmaceutical companies.   There are fundamental differences between medical device companies and #pharmaceutical: ► Medical device products are typically mechanical and require hardware to build. Pharmaceutical products on the other hand are mostly chemical. ► Time to market is usually shorter for medical device products (2-3 years) compared to pharmaceuticals (5-10 years), as they usually require comprehensive clinical trials. ► Pharmaceuticals have a much higher barrier to entry thanks to their strong IP portfolio and the long-term capital-intensive nature of their business.   Johnson & Johnson   In 2022, J&J reported $95B in annual #revenue with the following breakdown: -         Pharmaceutical (55%) -         MedTech (29%) -         Consumer Health (16%) On the expense side, J&J reported -         Cost of Revenue (32%) -         SG&A (26%) -         R&D (15%) and the remaining $18B as Net #Income (19%).   Roche   In 2022, Roche reported $70B in annual revenue with the following breakdown: -         Pharmaceutical (70%) -         Diagnostics Division (26%) -         Royalties (4%) On the expense side, Roche reported -         Cost of Revenue (30%) -         SG&A (19%) -         R&D (24%) and the remaining $14B as Net Income (20%).   Merck   In 2022, Merck reported $59B in annual revenue with the following breakdown: -         Pharmaceutical (88%) -         Animal Health (9%) -         Other (3%) On the expense side, Merck reported -         Cost of Revenue (29%) -         SG&A (17%) -         R&D (23%) and the remaining $14B as Net Income (24%).   Looking at the #economics one can see that these pharmaceutical companies have much lower Cost of Revenue compared to #medicaldevice companies (30% vs 60%). This high gross margin allows the pharmaceutical company to spend a lot more on R&D activities while maintaining a high profit margin.   As I showed in my previous post, on average #medical device companies spend 7-9% of their revenue on their R&D activities. For pharmaceutical companies, this number can easily go up to 25% of the revenue. This is also true for their profit margin.  As I showed previously, on average medical device companies turn 5-10% of their revenue into profit. For pharmaceutical companies, this number can be as high as 25% of revenue.   Will write more about #bigpharma in my future posts. Happy #valentinesday

80% of pharmaceutical manufacturing facilities are struggling with skills mismatches and half of all executives say that recruiting experienced staff is challenging. How can you close the skills gap? Explore the answers in our paper: https://lnkd.in/dhYTwwdn #Talent #TalentAcquisition #Staffing #PharmaceuticalIndustry #Pharamceutical #Scientist

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬: 𝐀 𝐃𝐞𝐞𝐩 𝐃𝐢𝐯𝐞 𝐢𝐧𝐭𝐨 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲! In the highly regulated and innovation-driven pharmaceutical industry, #CompetitiveIntelligence (CI) is crucial for making informed strategic decisions. Here’s a step-by-step, in-depth guide to analyzing CI for pharmaceutical products: 🔬 1. Identify & Profile Key Competitors Start by identifying direct competitors (similar therapeutic areas or molecular targets) and indirect competitors (alternative treatments like biologics or devices). Use sources like #EvaluatePharma and #GlobalData to map out key players and their pipelines. 🧪 2. Analyze Competitors’ Product Pipelines Review the entire product lifecycle—from preclinical stages to post-marketing—using databases like #ClinicalTrials.gov, #Pharmaprojects, and #AdisInsight. Understand their pipeline status and compare the progress of their trials against your own. 📈 3. Assess Market Position, Sales, & Share Track the market share of your competitors' key drugs. Use sources like #IQVIA, #IMSHealth, and #Datamonitor to monitor sales data, revenue growth, pricing strategies, and reimbursement pathways. ⚖️ 4. Patent & Regulatory Intelligence Monitor competitors' patent filings, expirations, and regulatory milestones. Use tools like #DrugPatentWatch, #OrangeBook, and #PatBase to identify upcoming patent cliffs or generic challenges. Keep track of regulatory approvals and ongoing submissions from agencies like the #FDA, #EMA, and #MHRA. 📚 5. Monitor Competitor Clinical Trials Analyze ongoing clinical trials, especially pivotal Phase III studies. Use sources like #BioPharm Insight, #Citeline, and #PubMed for trial updates and #data releases. 💡 6. Competitive Pricing & Market Access Evaluate how competitors price their drugs and navigate market access hurdles. Analyze their #HTA submissions, #payernegotiations, and formulary inclusions. Tools like #GlobalPricingInnovations (GPI) and #Informa can help you track pricing trends. 📢 7. Competitor Marketing & Digital Strategies Monitor competitors' marketing campaigns and digital presence through tools like #Veeva, #Socialbakers, and #Google Trends. Assess their content strategies, social media reach, and medical education platforms. 🧠 8. SWOT Analysis & Strategic Implications Conduct a #SWOT analysis of your competitors by identifying their strengths, weaknesses, opportunities, and threats. Use these insights to anticipate market changes and strategize accordingly. 📝 9. #Forecasting & Scenario Planning Use the gathered intelligence to build scenarios and forecasts for market evolution. Tools like IMS Forecast or IQVIA Analytics help model market dynamics and future sales potential based on competitor actions. #branding #marketing #productmarketing #hr #UK # #marketresearch #productmanagement #pharmastrategy #pharmaindustry #competitiveintelligence

# The Interdisciplinary Approach to Pharmaceutical Innovation In the rapidly evolving world of pharmaceuticals, breakthrough discoveries and advancements often arise not from a single discipline, but from the synergistic collaboration of diverse fields of expertise. The pharmaceutical industry is a complex ecosystem that requires the integration of various professions to drive innovation and address the ever-changing challenges faced by patients and healthcare providers. # The Need for Cross-Functional Collaboration Developing a new drug or therapeutic solution is a multi-faceted process that demands the expertise and coordination of professionals from a wide range of backgrounds. From basic scientific research to clinical trials, regulatory approval, and commercialization, each stage of the pharmaceutical pipeline requires specialized knowledge and skills. # Research and Development At the foundation of pharmaceutical innovation are scientists and researchers from disciplines such as chemistry, biology, pharmacology, and materials science. These experts work together to identify novel drug targets, design and synthesize candidate molecules, and investigate their mechanisms of action and potential therapeutic applications. #Clinical Trials and Regulatory Affairs As candidate drugs progress through the clinical trial phase, healthcare professionals, including physicians, nurses, and clinical research coordinators, play a crucial role in evaluating the safety and efficacy of the new treatments. Regulatory experts, such as regulatory affairs specialists and quality assurance professionals, ensure that the drug development process adheres to stringent guidelines and requirements for market approval. # Manufacturing and Supply Chain The successful production and distribution of pharmaceuticals rely on the collaboration of engineers, technicians, logisticians, and supply chain managers. These professionals work to optimize manufacturing processes, ensure product quality, and develop efficient distribution networks to make the drugs accessible to patients worldwide. #Marketing and Patient Education Bringing a new drug to market requires effective communication and collaboration between pharmaceutical marketers, patient advocacy groups, and healthcare providers. These stakeholders work together to raise awareness, provide educational resources, and address the unique needs and concerns of patients and healthcare professionals. #The Rewards of Interdisciplinary Collaboration By fostering a culture of cross-functional collaboration, the pharmaceutical industry can unlock the full potential of its diverse talent pool and drive transformative breakthroughs. This interdisciplinary approach not only accelerates the development of novel therapies but also enhances patient outcomes, improves the efficiency of the healthcare system, and ultimately, contributes to the betterment of global public health.

❗ 📈 💲 BioPharma Talent Intelligence - Pt. 4 of 4: How #BioPharma companies can help drive operational success and competitive advantage via Hiring Strategy! We look at the direct impact that ineffective hiring strategies have on a Biopharma business, and how a proactive and strategic approach to #talentacquisition can ensure #Biopharma companies enhance their #recruitment efficiency, attract top talent, and minimise the time-to-fill for critical positions, ultimately driving organizational success and competitive advantage. #TalentIntelligence #HiringStrategy #CDMO #Biopharmaceutical #CellTherapy #GeneTherapy #Hiring #Talent

80% of pharmaceutical manufacturing facilities are struggling with skills mismatches and half of all executives say that recruiting experienced staff is challenging. How can you close the skills gap? Explore the answers in our paper: https://lnkd.in/ebSZCGye #Talent #TalentAcquisition #Staffing #PharmaceuticalIndustry #Pharamceutical #Scientist

Closing the skills gap in pharma. I expected that there was a talent supply issue, but didn't think to this extent. Scary when you think about it! 80% of pharmaceutical manufacturing facilities are struggling with skills mismatches and half of all executives say that recruiting experienced staff is challenging. https://lnkd.in/gs4B_RPc #Talent #TalentAcquisition #Staffing #PharmaceuticalIndustry #Pharamceutical #Scientist

80% of pharmaceutical manufacturing facilities are struggling with skills mismatches and half of all executives say that recruiting experienced staff is challenging. How can you close the skills gap? Explore the answers in our paper: https://lnkd.in/eTfD3RrQ #Talent #TalentAcquisition #Staffing #PharmaceuticalIndustry #Pharamceutical #Scientist